Reply to Comment on: “Glucagon-like peptide-1 receptor agonists and risk of systemic and ocular vascular complications in patients with type 2 diabetes and diabetic retinopathy”

American Journal of Ophthalmology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles